Pre-treatment Platelet Counts Associated With Prognosis in Stage 2-3 Rectal Cancer
Platelet counts at the time of initial diagnosis had prognostic value for patients with rectal adenocarcinoma receiving neoadjuvant treatment.
AACR 2016
4-miRNA Signature Associated With PFS in Patients With Melanoma Receiving Ipilimumab
A 4-microRNA signature is significantly associated with progression-free survival in patients with advanced melanoma treated with neoadjuvant ipilimumab.
Potential Biomarkers Identified for Patients With Prostate Cancer Treated With SBRT
Molecular pathways identified that may serve as potential biomarkers in prostate cancer treated with stereotactic body radiation therapy (SBRT).
Circulating FGF21 Found To Be a Diagnostic, Prognostic Marker in RCC
Serum fibroblast growth factor 21 (FGF21) is useful as a diagnostic and prognostic biomarker in patients with clear cell renal cell carcinoma (ccRCC).
Researchers Identify Potential Biomarkers for VEGFR TKIs in mRCC
Bcl-2 family member (BIM) expression and phosphoinositide 3 kinase R1 (PIK3R1) might be candidate biomarkers for renal cell carcinoma (mRCC).
Metformin Enhances Activity of Abiraterone, Enzalutamide
Metformin, a widely used oral anti-diabetic drug, enhanced the anti-prostate cancer activity of abiraterone and enzalutamide.
BRCA1, AEG1 Expression Do Not Impact Outcomes in Patients With NSCLC Receiving Erlotinib, Bevacizumab
BRCA1 and AEG1 mRNA expression levels do not significantly impact median progression-free survival in non-small cell lung cancer (NSCLC).
Co-targeting Pathways May Improve Efficacy of EGFR-TKIs in Lung Cancer
Treatment with a single epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) can no longer be considered adequate.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AACR 2016
Loading... 
Loading...